.terms_of_service_block{display:block;}.terms_of_service_block.terms_btn_toggle{display:none;}

Viatris Inc. Common Stock (NASDAQ:VTRS)

Home >> Stock >> Viatris Inc. Common Stock >> Ratio

Symbol VTRS
Exchange NASDAQ
Major index membership S&P 500
Current market capitalization 12.89B
Trailing 12-month net income -883.30M
Trailing 12-month sales revenue 15.03B
Current book value per share (BPS) 16.58
Current cash value per share (CPS) 1.66
Annual dividend payout -
Annual dividend accrual 0.48 (4.44%)
Dividend ex-date Nov 22, 2024
Number of full-time employees 38000
Stock with tradable options and short sales Yes / Yes
Last quarter sales surprise 0.96%
Distance from 20-day simple moving average (SMA20) -2.13%
Trailing 12-month price-to-earnings ratio (P/E ratio) -
Forward 12-month price-to-earnings ratio (P/E ratio) 4.16
Price-to-earnings growth (PEG) -
Trailing 12-month price-to-sales ratio (P/S ratio) 0.86
Current price-to-book ratio (P/B ratio) 0.65
Current price-to-cash ratio (P/C ratio) 6.53
Trailing 12-month price-to-free-cash-flow ratio (P/FCF ratio) 6.62
Most recent quick ratio 0.88
Most recent current ratio 1.43
Most recent debt-to-equity leverage (D/E ratio) 0.81
Most recent long-term-debt-to-equity leverage (LTD/E ratio) 0.73
Last quarter earnings-per-share (EPS) surprise 10.82%
Distance from 50-day simple moving average (SMA50) -8.66%
Trailing 12-month earnings-per-share (EPS) -0.74
Forward annual earnings-per-share (EPS) 2.60
Forward quarterly earnings-per-share (EPS) 0.57
Current earnings-per-share growth (EPSG) -8.62%
Forward earnings-per-share growth (EPSG) -3.22%
Long-term current earnings-per-share growth (EPSG) -2.97%
Long-term past earnings-per-share growth (EPSG) -41.87%
Long-term past sales revenue growth (SRG) 9.76%
Short-term earnings-per-share growth (EPSG) -148.59%
Short-term sales revenue growth (SRG) -2.55%
Last quarter earnings-per-share growth (EPSG) -71.23%
Last quarter sales revenue growth (SRG) -4.30%
Distance from 200-day simple moving average (SMA200) -6.80%
Insider stock ownership concentration 2.44%
Most recent change in insider ownership -2.09%
Institutional stock ownership concentration 82.80%
Most recent change in institutional ownership 4.69%
Trailing 12-month return on assets (ROA) -1.89%
Trailing 12-month return on equity (ROE) -4.35%
Trailing 12-month return on investment (ROI) -2.58%
Trailing 12-month gross profit margin (GPM) 40.92%
Trailing 12-month operating profit margin (OPM) 9.48%
Trailing 12-month net profit margin (NPM) -5.88%
Trailing 12-month dividend payout ratio 1059.60%
Earnings date before/after market open/close (BMO/AMC) Feb 27 BMO
Additional trade activity N/A
Number of outstanding shares 1.19B
Number of floating shares 1.16B
Number of short-interest shares 2.59%
Short interest ratio 3.30
Short interest dollar amount 30.13M
Trailing 52-week stock price range 9.93 - 13.62
Distance from 52-week high -20.69%
Distance from 52-week low 8.82%
Relative strength index (RSI) 35.63
Stock analysts' average recommendation (1=buy to 5=sell) 3.09
Current relative trading volume 1.05
Current average trading volume 9.14M
Current stock trading volume 9,587,946
Most recent weekly stock price performance 0.65%
Most recent monthly stock price performance -5.18%
Most recent quarterly stock price performance -16.47%
Most recent semi-annual stock price performance -5.26%
Most recent annual stock price performance -9.77%
Most recent year-to-date stock price performance -13.25%
Most recent stock market beta 0.89
Current average true range 0.26
Most recent weekly and monthly return volatility 1.85% 2.14%
Stock analysts' average target price 12.83
Previous stock price close-of-business 10.80
Current stock price 10.80
Most recent daily stock price performance 0.00%

Blog+More

China allows its renminbi currency to slide below the psychologically important threshold of 7-yuan per U.S. dollar.

Charlene Vos

2019-09-13 10:37:00 Friday ET

China allows its renminbi currency to slide below the psychologically important threshold of 7-yuan per U.S. dollar.

China allows its renminbi currency to slide below the key psychologically important threshold of 7-yuan per U.S. dollar. A currency dispute between the U.S.

+See More

President Donald Trump delivers his first state-of-the-union address.

Daphne Basel

2018-01-29 07:38:00 Monday ET

President Donald Trump delivers his first state-of-the-union address.

President Donald Trump delivers his first state-of-the-union address. Several key highlights touch on economic issues from fiscal stimulus and trade protect

+See More

A brief biography of Andy Yeh

Andy Yeh Alpha

2023-06-19 10:31:00 Monday ET

A brief biography of Andy Yeh

A brief biography of Andy Yeh Andy Yeh is responsible for ensuring maximum sustainable member growth within the Andy Yeh Alpha (AYA) fintech network plat

+See More

House of Representatives considers a government expenditure bill with border wall finance and so sets up a shutdown stalemate with Senate.

Laura Hermes

2018-12-23 13:39:00 Sunday ET

House of Representatives considers a government expenditure bill with border wall finance and so sets up a shutdown stalemate with Senate.

The House of Representatives considers a government expenditure bill with border wall finance and therefore sets up a shutdown stalemate with Senate. As fre

+See More

A small fraction of the population enjoys most capital and wealth creation.

Jacob Miramar

2017-03-15 08:46:00 Wednesday ET

A small fraction of the population enjoys most capital and wealth creation.

The heuristic rule of *accumulative advantage* suggests that a small fraction of the population enjoys a large proportion of both capital and wealth creatio

+See More

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Rose Prince

2018-10-15 09:33:00 Monday ET

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties such as cardiovascular medications an

+See More